Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

News from the CMSC Annual Meeting 2015

This month we are reporting from the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) that took place on May 27-30 in Indianapolis, we have summarized the following lectures for you:

MRI advances in spinal cord offer deeper understanding of MS by Omar Khan, MD, director of the Sastry Foundation Advanced Imaging Laboratory at Wayne State University in Detroit.

Nurses offer line of defense in MS nonadherence by Megan Weigel, DNP, ARNP-C, MSCN of Baptist Neurology in Jacksonville Beach, FL.

MRI can help or hinder treatment of MS by Jill Conway, MD, of the Carolinas HealthCare System in Charlotte, NC.

CMSC symposium weighs factors in choosing between MS therapies, symposium held by Stephen Krieger, MD, of Mount Sinai Medical Center in New York, Jacqueline Bernard, MD, of the University of Chicago, Marie Namey, APRN, MSCN, of the Mellen Center for MS Treatment & Research in Cleveland, Michael Racke, MD, of Ohio State University.

Best practices offer guidance on treating MS in an evolving landscape by Corey Ford, MD, of the Multiple Sclerosis Specialty Clinic at the University of New Mexico.


About the Editors

  • Prof Timothy Vartanian

    Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
  • Dr Claire S. Riley

    Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...

Upcomming congresses

Search this site

Search form


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe »

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

The Grant for Multiple Sclerosis Innovation
supports promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients.  For full information and application details, please click here

Journal Editor's choice

Recommended by Prof. Fred Lublin

Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis

Magda Zakarian
Multiple Sclerosis and Related Disorders; Volume 4, Issue 3